Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

4D Molecular Doses First Patient in 4D-310 Trial for Fabry Disease

americanpharmaceuticalreviewMarch 16, 2021

Tag: Fabry disease , 4D-310 , 4D Molecular

PharmaSources Customer Service